Showing results (81-90 of 617) with videos related to

Sort By:
Pageof 62
Asian Journal of Surgery|February 7, 2024
A pathologic scoring system for predicting postoperative prognosis in patients with ruptured hepatocellular carcinomaFeng Xia, Qiao Zhang, Guobing Xia, et al.
Experimental Hematology & Oncology|November 11, 2022
Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedsideYiyang Liu, Yufei Wang, Sheng Sun, et al.
Oncotarget|September 18, 2015
Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesisJian Chang, Jean Vacher, Bing Yao, et al.
Oncology Reports|December 10, 2015
Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascadeBinhao Zhang, Chao Leng, Chao Wu, et al.
Frontiers in Surgery|April 8, 2022
Effect of Perioperative Blood Transfusion on the Postoperative Prognosis of Ruptured Hepatocellular Carcinoma Patients With Different BCLC Stages: A Propensity Score Matching AnalysisFeng Xia, Qiao Zhang, Zhiyuan Huang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 8, 2021
Pharmacokinetic Drug-Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2020: Mechanistic Understanding and Clinical RecommendationsJingjing Yu, Yan Wang, Isabelle Ragueneau-Majlessi
Clinical Therapeutics|May 11, 2024
Risk of Enzyme- and Transporter-mediated Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2022: A Detailed Analysis of In Vitro and Clinical Data Available in New Drug Application ReviewsJingjing Yu, Yan Wang, Isabelle Ragueneau-Majlessi
Clinical Therapeutics|October 9, 2022
Strong Pharmacokinetic Drug-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2021: Mechanisms and Clinical ImplicationsJingjing Yu, Yan Wang, Isabelle Ragueneau-Majlessi
International Journal of Biological Sciences|September 13, 2021
The role of RNA m5C modification in cancer metastasisQiaofeng Zhang, Furong Liu, Wei Chen, et al.
Frontiers in Pharmacology|October 2, 2019
Protective Effects of Dioscin Against Doxorubicin-Induced Hepatotoxicity Via Regulation of Sirt1/FOXO1/NF-κb SignalShasha Song, Liang Chu, Huifang Liang, et al.
Pageof 62